NASIR SHAHAB MD NPI 1407801061

NPI Details

Nasir Shahab, MD is a hematology and oncology internal medicine in Lisle, IL with 37 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Nasir Shahab, MD NPI is 1407801061. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

430 WARRENVILLE RD
300
LISLE, IL
ZIP 60532
Phone: (630) 364-7850
Fax: (630) 432-6604

The NPI 1407801061 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, pegfilgrastim-cbqv, biosimilar, (udenyca), 0.5 mg (HCPCS:Q5111)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Iron binding capacity (HCPCS:83550)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Red blood count, automated test (HCPCS:85045)
• Magnesium level (HCPCS:83735)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Blood creatinine level (HCPCS:82565)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Phosphate level (HCPCS:84100)
• Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Folic acid level, serum (HCPCS:82746)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)

The enumeration date for this NPI number is 5/23/2006 and was last updated on 8/22/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: